Description
Tirzepatide is a dual GIP and GLP-1 receptor agonist that significantly reduces body weight (up to 21% in studies) and improves glycemic control by regulating appetite and enhancing fat metabolism.
End of Content.
303-981-3117
End of Content.
+08 9229 8228
In Stock
Tirzepatide is a dual GIP and GLP-1 receptor agonist that significantly reduces body weight (up to 21% in studies) and improves glycemic control by regulating appetite and enhancing fat metabolism.
Tirzepatide is a dual GIP and GLP-1 receptor agonist that significantly reduces body weight (up to 21% in studies) and improves glycemic control by regulating appetite and enhancing fat metabolism.
Reviews
There are no reviews yet.